XLI drops another 3.2% on the week to $172.73, but the most striking development is a sudden tightening in the borrow market — availability collapsed from roughly 248% a week ago to 138% today, even as short sellers continued to trim.
The borrow story has reversed sharply since the August 26 note. Availability had been expanding steadily through mid-August, reaching above 400% on August 19. It has since swung violently: availability briefly collapsed to just 37% on August 31 — the tightest read in months — before bouncing back to 138% by September 1. That mid-week spike in tightness is notable. It suggests a sudden surge in borrowing demand on Monday, which then partially unwound. The 52-week low in availability is 2.1%, so the market is not in distress territory, but a move from 400% to 37% in two weeks is a meaningful change in the lending landscape. Cost to borrow remains low at 0.58%, down around 9% on the week, so the squeeze on availability hasn't yet translated into a pricing signal.
Short interest itself continued to ease — the opposite of what the Monday availability spike might imply. Shorts fell 4.3% on the week to 19.1 million shares, or 12.5% of free float. That is broadly flat over the past month, up just 3%, after a period of more active rebuilding in late July. The short score eased to 64.4 from a mid-week peak of 67.7 on August 31, when availability was at its tightest. The divergence is worth naming: borrow demand clearly spiked on Monday while reported short interest fell — that pattern is more consistent with hedging or tactical ETF creation/redemption mechanics than with a fresh directional short bet being put on.
Options positioning has calmed relative to the spike flagged in the prior note. The put/call ratio is running at 2.70, right on its 20-day average of 2.73 — the z-score is essentially flat at -0.19. The structural skew toward puts on XLI remains a persistent feature; the 52-week low on the PCR is 2.01, well above parity, reflecting the ETF's utility as a hedging vehicle for industrial exposure. But the elevated put-buying that pushed the PCR to 3.09 in late August has faded. Demand for downside protection is present but no longer accelerating.
The institutional picture from Q2 13-F filings shows mixed flows. Goldman Sachs trimmed its position by 1.65 million shares in the quarter. JPMorgan cut by nearly 1 million shares. Morgan Stanley, the largest reported holder at 6.7% of shares, also reduced by 653,000 shares. On the other side, Wells Fargo added 466,000 shares and Fisher Asset Management built its position by 886,000 shares. The net read from the top holders is cautious rather than bullish — three of the five largest names were sellers in Q2.
The key dynamic to watch next is whether the Monday availability squeeze was a one-off or the start of a more persistent tightening trend — and whether short interest, which has been grinding slowly lower, holds above the 12% free-float level or continues to ease as the industrial sector faces a fourth consecutive week of price pressure.
See the live data behind this article on ORTEX.
Open XLI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
